ARCHIVES

Glaxo, Mass General Begin Phase III Trial Of Tykerb

This article is from The Cancer Letter archive.

Vol. 29 No. 12 | December 29, 2006

Download PDF Visit The Full Archive

Related Articles

NCCS Networker Volume 3 Issue 4, Fall 1989

September 13, 1989

Cancer Panel To Form Committee On Breast Cancer

October 11, 1991

First NCAB “Road” Hearing In L.A.

September 18, 1987

Over Half of ALK-Positive NSCLC Patients Responded To Crizotinib In Colorado Study

November 26, 2010

DCT Bard Okays Concepts for BRMP Contract Programs

June 22, 1984

Freestanding Cancer Centers May Be The “Missing Ingredient In Cancer Treatment,” DeVita Believes

January 11, 1985